Ark Invest purchased shares of CRISPR Therapeutics AG for both its ARK Genomic Revolution ETF ARKG and Ark Innovation ETF ARKK. The ARKG ETF bought 43,467 shares, while the ARKK ETF acquired 248,748 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback